The use of rituximab in refractory mucous membrane pemphigoid with severe ocular involvement

British Journal of Ophthalmology

Volumn 93, Issue 4, 2009, Pages

  Ross, A H ^a   Jaycock, P ^a   Cook, S D ^a   Dick, A D ^a   Tole, D M ^a  

^a BRISTOL EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; CYCLOPHOSPHAMIDE; DAPSONE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; BIOPSY; BLISTER; CASE REPORT; CONJUNCTIVITIS; DYSPHAGIA; EYE DISEASE; HOARSENESS; HUMAN; MALE; MUCOUS MEMBRANE PEMPHIGOID; PENIS DISEASE; PRIORITY JOURNAL; SCAR FORMATION; SYMBLEPHARON;

ADULT; ANTIBODIES, MONOCLONAL; AUTOIMMUNE DISEASES; CHRONIC DISEASE; CONJUNCTIVITIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PEMPHIGOID, BENIGN MUCOUS MEMBRANE;

EID: 64849105636     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2007.129510     Document Type: Article

References (21)

1. Von Hippel E. Uber eine sehr self seltene Erkrankung der Netzhaut. Graefes Arch Ophthalmol 1904;59:83-106.
2. Magnus H. Aneurysma arteriovenosum retinale. Virch Arch Path Anat 1874;60:38-44.
3. Fuchs EF. Aneurysma arterio-venosum retinae. Arch Augenheilk 1882;11:440-4.
4. Collins ET. Two cases, brother and sister, with peculiar vascular new growth probably primarily retinal, affecting both eyes. Trans Opthalmol Soc UK 1894;14:141-9.
5. Wood DJ. Retinal detachment with unusual dilation of retinal vessels and other changes. Trans Ophthalmol Soc UK 1892;12:143.
6. Coats G. Forms of retinal disease with massive exudation. Royal Lond Ophthal Hosp Rep 1908;17:440-96.
7. Lindau A. Studien ber Kleinbirncysten Bau. Pathogenese und Beziehungen zur Angiomatosis Retinae. Acta Pathol Microbiol Scand 1926;3(Suppl 1):1-28.
8. Melmon KL, Rosen SW. Lindau's disease. Am J Med 1964;36:595-617.
9. Brandt R: Zur Frage der Angiomatosis retinae. Von Graefes Arch Ophth 1921;106:127-64.
10. Tauber J, Jabbur N, Foster S. Improved detection of disease progression in ocular cicatricial pemphigoid. Cornea 1992;11:446- 51.
11. Frith PA, Venning VA, Wojnarowska F, et al. Conjunctival involvement in cicatricial and bullous pemphigoid: A clinical and immunopathological study. Br J Ophthamol 1989;73:52-6.
12. Mondino BJ, Brown SI. Immunosupressive therapy in ocular cicatricial pemphigoid. Am J Ophthamol 1983;96:453-9.
13. Fern AI, Jay JL, Young H, et al. Dapsone therapy for the acute inflammatory phase of ocular pemphigoid. Br J Ophthalmol 1992;76:332-5.
14. Schmidt E, Seitz CS, Benoit S, et al. Rituximab in autoimmune bullous diseases: mixed responses and adverse effects. Br J Dermatol 2007;156:352-6.
15. Cheung CMG, Murray PI, Savage COS. Successful treatment of Wegener's granulomatosis associated scleritis with rituximab. Br J Ophthalmol 2005;89:1542.
16. Sami N, Bhol KC, Razzaque AA. Intravenous immunoglobulin therapy in patients with multiple mucosal involvement in mucous membrane pemphigoid. Clin Immunol 2002;102:59-67.
17. Rauz S, Maddison RGN, Dart JKG. Evaluation of mucous membrane pemphigoid with ocular involvement in young patients. Ophthalmology 2005;112:1268-74S.
18. Elder MJ, Bernauer W, Leonard J, et al. Progression of disease in ocular cicatricial pemphigoid. Br J Ophthalmol 1996;80:292-6.
19. Elder MJ, Lightman S, Dart JK. Role of cyclophosphamide and high dose steroid in ocular cicatricial pemphigoid. Br J Ophthalmol 1995;79:264-6.
20. Dick AD, Forrseter JV, Liversidge J, et al. The role of tumour necrosis factor (TNF-alpha) in experimental autoimmune uveoretinitis (EAU). Prog Retin Eye Res 2004;23:617-37.
21. Teoh SCB, Sharma S, Hogan A, et al. Tailoring biological treatment: anakinra treatment of posterior uveitis associated with the CINCA syndrome. Br J Ophthalmol 2007;91:263-4.